Neuroblastoma (NB), as the most common extracranial solid tumor in childhood, is one of the critical culprits affecting children’s health. Given the heterogeneity and invisibility of NB tumors, the existing diagnostic and therapeutic approaches are inadequate and ineffective in early screening and prognostic improvement. With the rapid innovation and development of nanotechnology, nanomedicines have attracted widespread attention in the field of oncology research for their excellent physiological and chemical properties. In this review, we first explored the current common obstacles in the diagnosis and treatment of NB. Then we comprehensively summarized the advancements in nanotechnology-based multimodal synergistic diagnosis and treatment of NB and elucidate the underlying mechanisms. In addition, a discussion of the pending challenges in biocompatibility and toxicity of nanomedicine was conducted. Finally, we described the development and application status of nanomaterials against some of the recognized targets in the field of NB research, and pointed out prospects for nanomedicine-based precision diagnosis and therapy of NB.
Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma
Hui Yan,B. Zhai,Fang Yang,Zhenliang Chen,Qiang Zhou,A. C. Paiva‐Santos,Ziqiao Yuan,Yang Zhou
Published 2022 in Frontiers in Pharmacology
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Frontiers in Pharmacology
- Publication date
2022-06-02
- Fields of study
Medicine, Materials Science, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-13 of 13 citing papers · Page 1 of 1